Association of CX36 Protein Encoding Gene
GJD2
RASGRF1
SNPs
astigmatism
hyperopia
myopia
refractive errors
Journal
Genes
ISSN: 2073-4425
Titre abrégé: Genes (Basel)
Pays: Switzerland
ID NLM: 101551097
Informations de publication
Date de publication:
28 06 2022
28 06 2022
Historique:
received:
29
04
2022
revised:
27
06
2022
accepted:
27
06
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Purpose: This study aimed to evaluate the associations of GJD2 (rs634990, rs524952) and RASGRF1 (rs8027411, rs4778879, rs28412916) gene polymorphisms with refractive errors. Methods: The study included 373 subjects with refractive errors (48 myopia, 239 myopia with astigmatism, 14 hyperopia, and 72 hyperopia with astigmatism patients) and 104 ophthalmologically healthy subjects in the control group. A quantitative real-time polymerase chain reaction (qPCR) method was chosen for genotyping. Statistical calculations and analysis of results were performed with IBM SPSS Statistics 27 software. Results: The correlations in monozygotic (MZ) twin pairs were higher compared to DZ pairs, indicating genetic effects on hyperopia and astigmatism. The heritability (h2) of hyperopia and astigmatism was 0.654 for the right eye and 0.492 for the left eye. The GJD2 rs634990 TT genotype increased the incidence of hyperopia with astigmatism by 2.4-fold and the CT genotype decreased the incidence of hyperopia with astigmatism by 0.51-fold (p < 0.05). The GJD2 rs524952 AT genotype reduced the incidence of hyperopia with astigmatism by 0.53-fold (p < 0.05). Haplotype analysis of SNPs in the GJD2 gene revealed two statistically significant haplotypes: ACTAGG for rs634990 and TTTAGA for rs524952, which statistically significantly reduced the incidence of hyperopia and hyperopia with astigmatism by 0.41-fold (95% CI: 0.220−0.765) and 0.383-fold (95% CI: 0.199−0.737), respectively (p < 0.05). It was also found that, in the presence of haplotypes ACTAGG for rs634990 and TATAGA for rs524952, the possibility of hyperopia was reduced by 0.4-fold (p < 0.05). Conclusions: the heritability of hyperopia and hyperopia with astigmatism was 0.654−0.492, according to different eyes in patients between 20 and 40 years. The GJD2 rs634990 was identified as an SNP, which has significant associations with the co-occurrence of hyperopia and astigmatism. Patients with the GJD2 gene rs634990 TT genotype were found to have a 2.4-fold higher risk of develop hyperopia with astigmatism.
Identifiants
pubmed: 35885949
pii: genes13071166
doi: 10.3390/genes13071166
pmc: PMC9319995
pii:
doi:
Substances chimiques
Connexins
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Commun Biol. 2021 Jun 3;4(1):676
pubmed: 34083742
Invest Ophthalmol Vis Sci. 2022 Mar 2;63(3):5
pubmed: 35262731
BMC Ophthalmol. 2014 Dec 23;14:163
pubmed: 25539893
Eur J Epidemiol. 2015 Apr;30(4):305-15
pubmed: 25784363
Curr Biol. 2019 Mar 4;29(5):763-774.e5
pubmed: 30799247
PLoS Genet. 2013;9(2):e1003299
pubmed: 23468642
Nat Genet. 2013 Mar;45(3):314-8
pubmed: 23396134
Exp Eye Res. 2019 Dec;189:107822
pubmed: 31585120
Sci Rep. 2017 Aug 11;7(1):7920
pubmed: 28801634
Eye (Lond). 2014 Feb;28(2):202-8
pubmed: 24406412
Sci Rep. 2016 Dec 5;6(1):9
pubmed: 28442706
Clin Genet. 2013 Aug;84(2):102-8
pubmed: 23647423
Prog Retin Eye Res. 2017 Nov;61:60-71
pubmed: 28602573
Biochim Biophys Acta Biomembr. 2018 Jan;1860(1):192-201
pubmed: 28457858
Invest Ophthalmol Vis Sci. 2013 Nov 13;54(12):7492-7
pubmed: 24150758
Oxid Med Cell Longev. 2015;2015:750637
pubmed: 25922643
J Clin Invest. 2017 Jun 30;127(7):2647-2661
pubmed: 28604388
Clin Ophthalmol. 2009;3:17-27
pubmed: 19668540
Brain Struct Funct. 2017 Aug;222(6):2603-2624
pubmed: 28070649
BMC Ophthalmol. 2018 May 24;18(1):124
pubmed: 29793445
Mol Vis. 2015 Nov 14;21:1272-80
pubmed: 26644762
Mol Vis. 2018 Feb 05;24:127-142
pubmed: 29422769
Invest Ophthalmol Vis Sci. 2016 Oct 01;57(13):5393-5404
pubmed: 27737460
Clin Genet. 2011 Apr;79(4):301-20
pubmed: 21155761
Chin Med J (Engl). 2019 Jul 20;132(14):1700-1705
pubmed: 31283648
PLoS One. 2014 Sep 18;9(9):e107110
pubmed: 25233373
Invest Ophthalmol Vis Sci. 2021 Apr 28;62(5):3
pubmed: 33909035